| GTO ID | GTC3707 |
| Trial ID | NCT06196658 |
| Disease | Pancreatic Cancer | Biliary Cancer |
| Altered gene | Ex02 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EX02 CAR T cells |
| Co-treatment | acetaminophen |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Early Phase I Study of Autologous T Cells Engineered to Express Anti-EX02 Chimeric Antigen Receptor (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer |
| Year | 2024 |
| Country | China |
| Company sponsor | Zhang Xiaofeng,MD |
| Other ID(s) | 20231226 |
| Cohort 1 | |||||||||||||
|
|||||||||||||